Rockwell Medical IN (RMTI)

Unicycive Therapeutics (Nasdaq: $UNCY ) announced that the company is scheduled to participate in the 25th Annual Needham Virtual Healthcare Conference. Shalabh Gupta, M.D., Chief Executive Officer, will present on Wednesday, April 15, 2026, at 3:45 p.m. ET. Unicycive is a B2i Digital Featured Company. See the full profile here: https://b2idigital.com/unicycive A link to the live and archived webcast is available on the Unicycive website under the Investors section: Events and Presentations. See the press release at https://ir.unicycive.com/news/detail/121/unicycive-therapeutics-to-present-at-the-25th-annual Unicycive Therapeutics is a clinical-stage biotechnology company developing novel treatments for kidney diseases. The company’s lead investigational treatment, oxylanthanum carbonate, is a novel phosphate-binding agent for treating hyperphosphatemia in patients with chronic kidney disease who are on dialysis and is currently under review by the U.S. Food and Drug Administration. Its second program, UNI-494, targets conditions related to acute kidney injury and has received FDA orphan drug designation for preventing delayed graft function in kidney transplant patients. Led by CEO Dr. Shalabh Gupta, MD and a seasoned executive team including CFO John Townsend, EVP Doug Jermasek, EVP Pramod Gupta, Dr. Atul Khare, Ph.D., M.B.A., and Dr. Guru Reddy, Unicycive is committed to addressing unmet needs in kidney disease treatment. Learn more about Unicycive Therapeutics at https://ir.unicycive.com and about other B2i Digital Featured Companies at https://b2idigital.com/featured-companies. Disclosure: David Shapiro, CEO of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted UNCY stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of UNCY or any security, and it is not intended to offer any opinion on UNCY as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the complete Disclosure in the Risks and Disclosures section of https://b2idigital.com/disclaimer. $XOMA, $RMTI, $LNTH, $XBI

$RMTI Will the contract be closed sooner or later or never? Let's see.

$RMTI So many words for the broken stock It’s hard to see in a crimson chart💔 So hard to breathe Hold with me and maybe!!!

$RMTI 06:36 on Mar. 30 2026 HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $2 #tradeideas

$RMTI 06:36 on Mar. 30 2026 HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $2 #tradeideas

$RMTI I'm laughing if they make the 100 million now with the new news that's about to arrive... I don't think so, but it would be fantastic if he said on purpose that in 2029 they would make over 100 million when instead we make it now, it would be a double rebound...

$RMTI If the news comes out in April I'll "lend" it to you because you're my friends and I want you to have fun too, but then I want it back!!!

$RMTI Will April be the start month? Before the Q1 earnings conference? It should build strong momentum before the conference if the announcement is good news.

$RMTI Now we have 30 days, then the NASDAQ notification arrives, and then another 180 days. Will Rockwell be able to demonstrate that it has turned the page and that it is now finally on the path to becoming a stable and growing company? I strongly believe so.